Get started
Work

Supplementary Figure S9 from Targeting AKR1B10 by Drug Repurposing with Epalrestat Overcomes Chemoresistance in Non–Small Cell Lung Cancer Patient-Derived Tumor Organoids

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Figure S9. Dose titration of epalrestat against PDTOs to determine the cytotoxicity.
DOI: 10.1158/1078-0432.26926648
Authors: Kanve N. Suvilesh, Yariswamy Manjunath, Yulia I. Nussbaum, Mohamed Gadelkarim, Murugesan Raju, Akhil Srivastava, Guangfu Li, Wesley C. Warren, Chi-Ren Shyu, Feng Gao, Matthew A. Ciorba, Jonathan B. Mitchem, Satyanarayana Rachagani, Jussuf T. Kaifi
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4402207123
Cites:
Cited by:
Related to: 10